Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sertraline
Drug ID BADD_D02010
Description Sertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as [Citalopram] and [Fluoxetine]. Despite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects. Several weeks of therapy with sertraline may be required before beneficial effects are noticed. Sertraline displays enhanced safety or tolerability than other classes of antidepressants, which frequently cause high levels of drowsiness, dizziness, blurred vision, and other undesirable effects.[A1846,A187075,T28]
Indications and Usage Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD).[L9016] Common off-label uses for sertraline include the prevention of post stroke depression[A187078], generalized anxiety disorder (GAD), fibromyalgia, premature ejaculation, migraine prophylaxis, diabetic neuropathy, and neurocardiogenic syncope.[L5227]
Marketing Status approved
ATC Code N06AB06
DrugBank ID DB01104
KEGG ID D02360
MeSH ID D020280
PubChem ID 68617
TTD Drug ID D0K0TC
NDC Product Code 76282-214; 23155-759; 68180-353; 55700-225; 63187-055; 70518-0153; 70518-1461; 70518-1617; 71335-9714; 0615-7990; 65427-009; 55154-3570; 0615-7991; 76282-212; 0904-6924; 50090-5848; 70518-1040; 23155-757; 70518-2512; 0904-6925; 68180-351; 68180-352; 68071-4400; 63187-212; 68788-7329; 0615-7989; 0904-6926; 55154-3569; 63187-478; 67296-1199; 70934-958; 76282-213; 23155-758; 50090-0989
UNII QUC7NX6WMB
Synonyms Sertraline | Zoloft | Altruline | Lustral | Apo-Sertraline | Apo Sertraline | Aremis | Besitran | Sealdin | Gladem | Novo-Sertraline | Novo Sertraline | ratio-Sertraline | ratio Sertraline | Rhoxal-sertraline | Rhoxal sertraline | Sertraline Hydrochloride | Hydrochloride, Sertraline | Sertraline Hydrochloride (1S-cis)-Isomer | Gen-Sertraline | Gen Sertraline
Chemical Information
Molecular Formula C17H17Cl2N
CAS Registry Number 79617-96-2
SMILES CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypokinesia17.01.02.0090.000038%Not Available
Hypomania19.16.02.0010.000245%Not Available
Hyponatraemia14.05.04.0020.000937%
Hypopituitarism05.03.02.0010.000045%
Hypopnoea22.02.01.0210.000045%Not Available
Hyporeflexia17.02.01.003--
Hypotension24.06.03.002--
Hypothermia12.05.03.001; 08.05.01.0030.000057%
Hypothyroidism14.11.01.012; 05.02.03.0010.000089%
Hypotonia17.05.02.002; 15.05.04.0080.000089%Not Available
Hypotonia neonatal18.04.01.006; 17.05.02.010; 15.05.04.0120.000025%Not Available
Hypoventilation22.02.01.0070.000032%Not Available
Ileus paralytic07.02.05.0010.000032%Not Available
Illusion19.10.05.006--Not Available
Inappropriate affect19.04.01.0050.000051%Not Available
Incoherent19.10.03.006; 17.02.08.0020.000038%Not Available
Increased appetite14.03.01.003; 08.01.09.0270.000112%Not Available
Increased tendency to bruise24.07.06.012; 23.06.01.009; 01.01.03.0050.000019%Not Available
Infertility male21.03.02.0020.000013%Not Available
Influenza like illness08.01.03.0100.000243%
Inguinal hernia07.16.02.0010.000013%Not Available
Injection site erythema12.07.03.001; 08.02.03.001; 23.03.06.0150.000164%Not Available
Injection site hypersensitivity12.07.03.006; 10.01.03.017; 08.02.03.0060.000028%Not Available
Injection site induration12.07.03.007; 08.02.03.0070.000136%Not Available
Injection site mass12.07.03.010; 08.02.03.0090.000201%Not Available
Injection site pain12.07.03.011; 08.02.03.0100.000382%Not Available
Injection site reaction12.07.03.015; 08.02.03.0140.000359%
Injection site urticaria23.04.02.003; 12.07.03.029; 10.01.06.003; 08.02.03.0290.000043%Not Available
Injection site warmth12.07.03.036; 08.02.03.0360.000043%Not Available
Insomnia19.02.01.002; 17.15.03.0020.001762%
The 12th Page    First    Pre   12 13 14 15 16    Next   Last    Total 36 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene